查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1682037

2025年细胞裂解和分馏全球市场报告

Cell Lysis And Fractionation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年细胞裂解和分馏市场规模将强劲成长。到 2029 年，这一数字将成长至 48.9 亿美元，复合年增长率为 7.0%。预测期内的成长可归因于对个人化医疗的日益关注、政府对研究的资助增加、对有效方法的高需求、基因组学和蛋白​​质组学领域的技术进步以及慢性病和感染疾病病率的上升。预测期内的关键趋势包括个人化医疗方法的采用持续增长、裂解和分馏过程中自动化和机器人技术的提高、临床诊断和药物开发中的应用不断扩大、用于细胞分析的微流体和实验室晶片技术的进步，以及对照护现场和分散式检查解决方案的日益重视。

个人化医疗日益受到关注预计将在未来几年推动细胞裂解和分馏市场的成长。个人化医疗是一种新兴的医疗实践，利用个人的基因特征来诊断和治疗疾病。它涉及根据每个患者的独特特征量身定制医疗决策和治疗，特别关注他们的基因组成。细胞裂解和分馏在精准医疗中发挥关键作用，因为它能够从患者样本中分离和分析特定的亚细胞成分，例如蛋白质、细胞器和核酸。这使得科学家和医疗专业人员能够研究疾病背后的分子过程，并根据每位患者独特的分子特征制定客製化治疗方案。例如，根据致力于促进个人化医疗理解和传播的美国组织个人化医疗联盟（PMC）预测，到2022年10月，市场上将有超过75,000种基因检测产品和超过300种个人化药物，用于治疗多种癌症、罕见遗传疾病以及多种慢性病和感染疾病。因此，对个人化医疗的日益关注正在推动细胞裂解和分馏市场的成长。

细胞裂解和分馏市场的主要企业正专注于引入先进的解决方案，例如 CGT（细胞和基因疗法）病毒载体裂解试剂套件，以在市场上获得竞争优势。这些裂解套件提供了一种简化的 AAV（腺结合病毒）裂解方法，标准化了生物製程工作流程，同时改善了 SOP（标准操作程序）、品管和安全性。例如，2023年7月，德国样本和检测技术供应商QIAGEN推出了新的CGT病毒载体裂解套件。该套件可以从细胞裂解物开始，以准确、统一的程序对几种血清型的病毒滴度进行量化。新型 CGT 病毒载体裂解试剂套件是对 QIAGEN 为生物製药行业快速扩展的数位 PCR 产品组合的补充，该产品组合已包括三种 QIAcuity 残留 DNA 定量试剂盒（用于检查宿主细胞 DNA 的残留）和 10 种 QIAcuity 细胞和基因治疗 (CGT) dPCR 检测试剂盒（用于腺结合病毒滴度）。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球细胞裂解和分馏 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球细胞裂解与分馏市场：成长率分析
  • 全球细胞裂解与分馏市场表现：规模与成长，2019-2024
  • 全球细胞裂解与分馏市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球细胞裂解和分馏总目标市场（TAM）

第六章市场区隔

  • 全球细胞裂解和分馏市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 哺乳动物细胞
  • 微生物细胞
  • 全球细胞裂解和分馏市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 核酸精製与分离
  • 蛋白质精製与分离
  • 全球细胞裂解和分馏市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 研究室和实验室
  • 生物製药
  • 生技公司
  • 全球细胞裂解和分馏市场、哺乳动物细胞细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 贴壁哺乳动物细胞
  • 悬浮哺乳动物细胞
  • 初代细胞
  • 细胞株
  • 全球细胞裂解和分馏市场微生物细胞细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 细菌细胞
  • 酵母菌细胞
  • 真菌细胞
  • 藻类细胞

第七章 区域和国家分析

  • 全球细胞裂解及分馏市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球细胞裂解和分馏市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 细胞裂解与分馏市场：竞争格局
  • 细胞裂解和分馏市场：公司简介
    • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Lonza Group AG
  • Illumina Inc.
  • Beckman Coulter Inc.
  • PerkinElmer Inc.
  • IDEX Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf AG
  • Miltenyi Biotec BV & Co. KG
  • Promega Corporation
  • Takara Bio Inc.
  • Abcam plc
  • Cell Signaling Technology Inc.
  • BioVision Inc.
  • Diagenode LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年细胞裂解和分馏市场：提供新机会的国家
  • 2029年细胞裂解与分馏市场：细分市场带来新机会
  • 2029年细胞裂解与分馏市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r27643

Cell lysis is the process of breaking open a cell, which allows the release of its contents, while cell fractionation is a multi-step laboratory procedure used to divide a cell's organelles into various layers or fractions or sections.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The cell lysis and fractionation market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.72 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing investments in life science research, growing focus on personalized medicine, high prevalence of diseases, technological advancements in cell lysis and fractionation methods, rising demand for biopharmaceuticals and biotechnology products.

The cell lysis and fractionation market size is expected to see strong growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing focus on personalized medicine, increasing government funding for research, high demand for effective cell lysis and fractionation methods, technological advancements in the field of genomics and proteomics, rising prevalence of chronic and infectious diseases. Major trends in the forecast period include continued growth in the adoption of personalized medicine approaches, increasing integration of automation and robotics in lysis and fractionation processes, expansion of applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, growing emphasis on point-of-care and decentralized testing solutions.

A growing focus on personalized medicine is expected to propel the growth of the cell lysis and fractionation markets going forward. Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile for the diagnosis and treatment of disease. It involves tailoring medical decisions and treatments to the individual characteristics of each patient, particularly focusing on their genetic makeup. Cell lysis and fractionation play a crucial part in precision medicine by making it possible to separate and analyze particular subcellular elements from patient samples, including proteins, organelles, and nucleic acids. This makes it possible for scientists and medical professionals to investigate the molecular processes that underlie illness and create customized treatments depending on the unique molecular traits of each patient. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the growing focus on personalized medicine is driving the growth of the cell lysis and fractionation markets.

Major companies operating in the cell lysis and fractionation market are focused on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive edge in the market. These lysis kits offer a simplified AAV (Adeno-associated virus) lysis methodology that will improve SOPs (Standard Operating Procedures), quality control, and safety while standardizing bioprocessing workflows. For instance, in July 2023, QIAGEN, a Germany-based provider of sample and assay technologies, launched the new CGT Viral Vector Lysis Kit, which makes it possible to quantify virus titers for several serotypes with an exact and uniform procedure starting with cell lysates. The new CGT viral vector lysis kit complements QIAGEN's rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to check for host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

In December 2022, MilliporeSigma, a US-based pharmaceutical company, acquired Erbi Biosystems Inc. for an undisclosed amount. With this acquisition, MilliporeSigma aims to strengthen its portfolio and expertise in the field of bioreactors and cell culture technologies. Erbi Biosystems is the developer of the 2 ml micro-bioreactor platform technology known as Breez, which is a micro-scale, fully automated, functionally closed system. Erbi Biosystems Inc. is a US-based biotechnology company that offers microfluidic solutions to enable efficient and controlled cell lysis and fractionation.

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Fractionation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell lysis and fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Mammalian Cells; Microbial Cells
  • 2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
  • 3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
  • Subsegments:
  • 1) By Mammalian Cells: Adherent Mammalian Cells; Suspension Mammalian Cells; Primary Cells; Cell Lines
  • 2) By Microbial Cells: Bacterial Cells; Yeast Cells; Fungal Cells; Algal Cells
  • Companies Mentioned: Hoffmann-La Roche Ltd; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Lysis And Fractionation Market Characteristics

3. Cell Lysis And Fractionation Market Trends And Strategies

4. Cell Lysis And Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Lysis And Fractionation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell Lysis And Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell Lysis And Fractionation Market Growth Rate Analysis
  • 5.4. Global Cell Lysis And Fractionation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell Lysis And Fractionation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell Lysis And Fractionation Total Addressable Market (TAM)

6. Cell Lysis And Fractionation Market Segmentation

  • 6.1. Global Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian Cells
  • Microbial Cells
  • 6.2. Global Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Purification And Isolation
  • Protein Purification And Isolation
  • 6.3. Global Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories And Institutes
  • Biopharmaceutical
  • Biotechnology Companies
  • 6.4. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Mammalian Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherent Mammalian Cells
  • Suspension Mammalian Cells
  • Primary Cells
  • Cell Lines
  • 6.5. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Microbial Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Cells
  • Yeast Cells
  • Fungal Cells
  • Algal Cells

7. Cell Lysis And Fractionation Market Regional And Country Analysis

  • 7.1. Global Cell Lysis And Fractionation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell Lysis And Fractionation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Lysis And Fractionation Market

  • 8.1. Asia-Pacific Cell Lysis And Fractionation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Lysis And Fractionation Market

  • 9.1. China Cell Lysis And Fractionation Market Overview
  • 9.2. China Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Lysis And Fractionation Market

  • 10.1. India Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Lysis And Fractionation Market

  • 11.1. Japan Cell Lysis And Fractionation Market Overview
  • 11.2. Japan Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Lysis And Fractionation Market

  • 12.1. Australia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Lysis And Fractionation Market

  • 13.1. Indonesia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Lysis And Fractionation Market

  • 14.1. South Korea Cell Lysis And Fractionation Market Overview
  • 14.2. South Korea Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Lysis And Fractionation Market

  • 15.1. Western Europe Cell Lysis And Fractionation Market Overview
  • 15.2. Western Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Lysis And Fractionation Market

  • 16.1. UK Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Lysis And Fractionation Market

  • 17.1. Germany Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Lysis And Fractionation Market

  • 18.1. France Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Lysis And Fractionation Market

  • 19.1. Italy Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Lysis And Fractionation Market

  • 20.1. Spain Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Lysis And Fractionation Market

  • 21.1. Eastern Europe Cell Lysis And Fractionation Market Overview
  • 21.2. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Lysis And Fractionation Market

  • 22.1. Russia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Lysis And Fractionation Market

  • 23.1. North America Cell Lysis And Fractionation Market Overview
  • 23.2. North America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Lysis And Fractionation Market

  • 24.1. USA Cell Lysis And Fractionation Market Overview
  • 24.2. USA Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Lysis And Fractionation Market

  • 25.1. Canada Cell Lysis And Fractionation Market Overview
  • 25.2. Canada Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Lysis And Fractionation Market

  • 26.1. South America Cell Lysis And Fractionation Market Overview
  • 26.2. South America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Lysis And Fractionation Market

  • 27.1. Brazil Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Lysis And Fractionation Market

  • 28.1. Middle East Cell Lysis And Fractionation Market Overview
  • 28.2. Middle East Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Lysis And Fractionation Market

  • 29.1. Africa Cell Lysis And Fractionation Market Overview
  • 29.2. Africa Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Lysis And Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Cell Lysis And Fractionation Market Competitive Landscape
  • 30.2. Cell Lysis And Fractionation Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Cell Lysis And Fractionation Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Illumina Inc.
  • 31.3. Beckman Coulter Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. IDEX Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN NV
  • 31.8. Eppendorf AG
  • 31.9. Miltenyi Biotec B.V. & Co. KG
  • 31.10. Promega Corporation
  • 31.11. Takara Bio Inc.
  • 31.12. Abcam plc
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioVision Inc.
  • 31.15. Diagenode LLC

32. Global Cell Lysis And Fractionation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Lysis And Fractionation Market

34. Recent Developments In The Cell Lysis And Fractionation Market

35. Cell Lysis And Fractionation Market High Potential Countries, Segments and Strategies

  • 35.1 Cell Lysis And Fractionation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell Lysis And Fractionation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell Lysis And Fractionation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer